Skip to main content

Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects

Abstract

CD8+ cytotoxic T lymphocyte (CTL) activity is currently believed to be one of the key immunologic mechanisms responsible for the prevention or attenuation of HIV-1 infection. The induction of CD8+ T cell activation may also result in the production of soluble or non-classical lytic factors that are associated with protection from infection or slower disease progression. Traditionally, CD8+ CTL responses have been measured by the classic chromium release assay, monitoring the ability of T cells (Effector cells) to lyse radiolabelled HLA — matched “target cells“ that express the appropriate antigen-MHC complex. This method is not only labor intensive, semi quantitative assay at best, but also needs fresh, non-cryopreserved cells. Recently, cytokine specific ELISPOT assays or tetrameric MHC-I/ peptide complexes have utilized to directly quantitate circulating CD8+ effector cells, and these assays are more sensitive, quantitative and reproducible than the traditional CTL lysis assay and can also be performed on cryopreserved cells. Although these are reproducible assays for the assessment of soluble antiviral activity secreted by activated T cell populations they can be extremely expensive to perform. We have used FACS Analysis to measure Granzyme B release as a function of cell mediated cytotoxicity. This method helps quantitate the CTL activity and also identifies the phenotype of the cells elucidating this immune response. The method described not only monitors immunological response but also is also simple to perform, precise and extremely time efficient and is ideal for screening a large number of samples.

Abbreviations

CTL:

cytotoxic T lymphocyte

HIV:

Human Immunodeficiency Virus

NK:

natural killer

PI:

propidium iodide

7AAD:

7-aminoactinomycin D

PBMCs:

peripheral blood mononuclear cells

E:T:

Effector: Target

R1 / R2:

Region 1/Region 2

FL-1:

fluorescence axis 1

FL-2:

fluorescence axis 2

SSC:

side scatter

PE:

phycoerythrin

References

  1. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT. HIV-specific cytotoxic T lymphocytes in seropositive individuals.Nature 1987; 328:345–348.

    Article  PubMed  CAS  Google Scholar 

  2. Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.Lancet 1994; 344:1671–1673.

    Article  PubMed  CAS  Google Scholar 

  3. Scheibenbogen C, Romero P, Rivoltini L, Herr W, Schmittel A, Cerottini JC, Woelfel T, Eggermont AM. Quantitation of antigen reactive T cells in peripheral blood by IFN gamma - ELISPOT assay and Chromium - release assay: a four center comparative trial.J Immunol Methods 2000; 244(1–2):81–89.

    Article  PubMed  CAS  Google Scholar 

  4. Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell Immunity.J Immunol Methods 2000; 240(1–2):143–155.

    Article  PubMed  CAS  Google Scholar 

  5. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.Adv Exp Med Biol 1998; 452:123–142.

    PubMed  CAS  Google Scholar 

  6. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes.Science 1996; 274(5284):94–96.

    Article  PubMed  CAS  Google Scholar 

  7. Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr, Tellez I, McPherson SA, Sabbaj S, Mulligan MJ. A significant number of human immunodeficiency virus epitope- specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.J Virol 2000; 74(21):10249–10255.

    Article  PubMed  CAS  Google Scholar 

  8. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJ, Hack CE. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.Clin Exp Immunol 1995; 100(1):164–172.

    Article  PubMed  CAS  Google Scholar 

  9. Derby E, Reddy V, Baseler M, Malyguine A. Flow cytometric assay for the simultaneous Analysis of cell mediated cytotoxicity and effector cell phenotype.Biotechniques 2001; 31:660–665.

    PubMed  CAS  Google Scholar 

  10. Kroemer G. The pharmacology of T cell apoptosis.Adv Immunol 1995; 58:211–296.

    Article  PubMed  CAS  Google Scholar 

  11. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.Blood 1994; 84(5):1415–1420.

    PubMed  CAS  Google Scholar 

  12. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.Immunol Methods 1995; 184(1):39–51.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Supriya D. Mahajan Ph.D..

Additional information

Published: September 5, 2003

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahajan, S.D., Aalinkeel, R., Schwartz, S.A. et al. Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects. Biol. Proced. Online 5, 182–188 (2003). https://doi.org/10.1251/bpo60

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1251/bpo60

Indexing terms